T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis

Clinical Immunology

Volumn 111, Issue 1, 2004, Pages 53-60

  Klehmet, Juliane ^a   Shive, Carey ^a   Guardia Wolff, Rocio ^a   Petersen, Ines ^b   Spack, Edward G ^c   Boehm, Bernhard O ^d   Weissert, Robert ^b   Forsthuber, Thomas G ^a,e  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c InterMune Inc   (United States)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Central nervous system; CNS; EAE; Encephalomyelitis; Experimental autoimmune encephalomyelitis; Glycoprotein; MBP; MOG; MS; Multiple sclerosis; Myelin basic protein; Myelin oligodendrocyte glycoprotein; Oligodendrocyte

Indexed keywords

EPITOPE; HLA DR4 ANTIGEN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BINDING AFFINITY; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN PRESENTATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-DR4 ANTIGEN; HUMANS; MICE; MICE, TRANSGENIC; MYELIN-ASSOCIATED GLYCOPROTEIN; PEPTIDE FRAGMENTS;

EID: 1842685035     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clim.2003.12.012     Document Type: Article

References (37)

1. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358(6382):1992;155-157.
2. McRae B.L., Vanderlugt C.L., Dal C.M., Miller S.D. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J. Exp. Med. 182:1995;75-85.
3. Yu M., Johnson J.M., Tuohy V.K. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183(4):1996;1777-1788.
4. Jones R.E., Bourdette D., Moes N., Vandenbark A., Zamora A., Offner H. Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis. J. Immunol. 170(4):2003;1690-1698.
5. Tuohy V.K., Yu M., Weinstock-Guttman B., Kinkel R.P. Diversity and plasticity of self recognition during the development of multiple sclerosis. J. Clin. Invest. 99(7):1997;1682-1690.
6. Goebels N., Hofstetter H., Schmidt S., Brunner C., Wekerle H., Hohlfeld R. Repertoire dynamics of autoreactive T cells in multiple sclerosis patients and healthy subjects: epitope spreading versus clonal persistence. Brain. 123(Pt 3):2000;508-518.
7. Mazza G., Ponsford M., Lowrey P., Campbell M.J., Zajicek J., Wraith D.C. Diversity and dynamics of the T-cell response to MBP in DR2 + ve individuals. Clin. Exp. Immunol. 128(3):2002;538-547.
8. Ito K., Bian H.J., Molina M.et al. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J. Exp. Med. 183:1996;2635-2644.
9. Marrosu M.G., Muntoni F., Murru M.R.et al. Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurology. 38(11):1988;1749-1753.
10. Marrosu M.G., Murru M.R., Costa G.et al. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. [letter] Am. J. Hum. Genet. 61(2):1997;454-457.
11. Muraro P.A., Vergelli M., Kalbus M.et al. Immunodominance of a low-affinity major histocompatibility complex-binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1*0401) subjects is associated with a restricted T cell receptor repertoire. J. Clin. Invest. 100(2):1997;339-349.
12. Forsthuber T.G., Shive C.L., Wienhold W.et al. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells. J. Immunol. 167(12):2001;7119-7125.
13. Rauch H.C., Einstein E.R., Csejtey J., Davis W.J. Protective action of the encephalitogen and other basic proteins in experimental allergic encephalomyelitis. Immunochemistry. 5:1968;567-575.
14. Congia M., Patel S., Cope A.P., De Virgiliis S., Sonderstrup G. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc. Natl. Acad. Sci. U. S. A. 95(7):1998;3833-3838.
15. Shive C.L., Hofstetter H., Arredondo L., Shaw C., Forsthuber T.G. The enhanced antigen-specific production of cytokines induced by pertussis toxin is due to clonal expansion of T cells and not to altered effector functions of long-term memory cells. Eur. J. Immunol. 30(8):2000;2422-2431.
16. Karulin A.Y., Hesse M.D., Tary-Lehmann M., Lehmann P.V. Single-cytokine-producing CD4 memory cells predominate in type 1 and type 2 immunity. J. Immunol. 164(4):2000;1862-1872.
17. M. Rocken, M. Racke, E.M. Shevach, IL-4 induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol. Today 17:275.
18. Hammer J., Bono E., Gallazzi F., Belunis C., Nagy Z., Sinigaglia F. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J. Exp. Med. 180(6):1994;2353-2358.
19. Weissert R., de Graaf K.L., Storch M.K.et al. MHC class II-regulated central nervous system autoaggression and T cell responses in peripheral lymphoid tissues are dissociated in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J. Immunol. 166(12):2001;7588-7599.
20. Ristori G., Giubilei F., Giunti D.et al. Myelin basic protein intramolecular spreading without disease progression in a patient with multiple sclerosis. J. Neuroimmunol. 110(1-2):2000;240-243.
21. Vergelli M., Mazzanti B., Traggiai E.et al. Short-term evolution of autoreactive T cell repertoire in multiple sclerosis. J. Neurosci. Res. 66(3):2001;517-524.
22. Weissert R., Kuhle J., de Graaf K.L.et al. High immunogenicity of intracellular myelin oligodendrocyte glycoprotein epitopes. J. Immunol. 169(1):2002;548-556.
23. Kaufman D.L., Clare-Salzler M., Tian J.et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. [see comments] Nature. 366:1993;69-72.
24. Zechel M.A., Krawetz M.D., Singh B. Epitope dominance: evidence for reciprocal determinant spreading to glutamic acid decarboxylase in non-obese diabetic mice. Immunol. Rev. 164:1998;111-118.
25. Tian J., Gregori S., Adorini L., Kaufman D.L. The frequency of high avidity T cells determines the hierarchy of determinant spreading. J. Immunol. 166(12):2001;7144-7150.
26. Uccelli A., Ristori G., Giunti D.et al. Dynamics of the reactivity to MBP in multiple sclerosis. J. Neurovirol. 6(Suppl. 2):2000;S52-S56.
27. Tuohy V.K., Yu M., Yin L.et al. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 164:1998;93-100.
28. Miller A., Lider O., Roberts A.B., Sporn M.B., Weiner H.L. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. Proc. Natl. Acad. Sci. U. S. A. 89(1):1992;421-425.
29. Sakaguchi S., Sakaguchi N. Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease. J. Immunol. 142(2):1989;471-480.
30. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155(3):1995;1151-1164.
31. Hofstetter H.H., Sewell D.L., Liu F.et al. Autoreactive T cells promote post-traumatic healing in the central nervous system. J. Neuroimmunol. 134(1-2):2003;25-34.
32. Klein L., Klugmann M., Nave K.A., Kyewski B. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. [see comments] Nat. Med. 6(1):2000;56-61.
33. Derbinski J., Schulte A., Kyewski B., Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat. Immunol. 2(11):2001;1032-1039.
34. Bruno R., Sabater L., Sospedra M.et al. Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus. Eur. J. Immunol. 32(10):2002;2737-2747.
35. Targoni O.S., Lehmann P.V. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187(12):1998;2055-2063.
36. Anderton S.M., Radu C.G., Lowrey P.A., Ward E.S., Wraith D.C. Negative selection during the peripheral immune response to antigen. J. Exp. Med. 193(1):2001;1-11.
37. Tian J., Lehmann P.V., Kaufman D.L. Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186(12):1997;2039-2043.